← Companies|Bausch Health
BH

Bausch Health

BHC·NYSELaval CAFounded 196021,000 employees
Mid CappharmaPublicOphthalmologyDermatologyGI
Platform: Specialty
Market Cap
$3B
All Drugs
3
Clinical Trials
7
Failed / Terminated
1
FDA Approved
2
Stock Price & Catalysts (BHC)
Loading BHC stock data...
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
TirabrutinibBHC-9621Approved3Gene TherapyCD3BETiPsoriasisObesity
BHC-6524BHC-6524Approved2siRNACl18.2BTKiCrohn'sNSCLC
BHC-1366BHC-1366Phase 12RadioligandCD123SOS1iDMD
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2026-01-24
BHC-1366 Interim
DMD
Past
2026-10-22
Tirabrutinib Ph3 Readout
Psoriasis
Ph3 Readout
2028-08-21
Tirabrutinib Ph3 Readout
Obesity
Ph3 Readout